Molecular Pharmaceutics
Article
(10) Felgner, P. L.; Gadek, T. R.; Holm, M.; Roman, R.; Fhan, H. W.;
Wenz, M.; Nortrop, J. P.; Ringold, G. M.; Danielsen, M. Lipofection: a
highly efficient, lipid-mediated DNA-transfection procedure. Proc.
Natl. Acad. Sci. U.S.A. 1987, 84, 7413−7417.
(29) Zuber, G.; Zammut-Italiano, L.; Dauty, E.; Behr, J.-P. Targeted
gene delivery to cancer cells: Directed assembly of nanometric DNA
particles coated with folic acid. Angew. Chem., Int. Ed. 2003, 42, 2666−
2669.
(30) Wetzer, B.; Byk, G.; Frederic, M.; Airiau, M.; Blanche, F.; Pitard,
B.; Scherman, D. Reducible cationic lipids for gene transfer. Biochem. J.
2001, 356, 747−756.
(31) Byk., G.; Wetzer, B.; Frederic, M.; Dubertret, C.; Pitard, B.;
Jalsin, G.; Scherman, D. Reduction-sensitive lipoplyamines as a novel
nonviral gene delivery system for modulated release of DNA with
improved transgene expression. J. Med. Chem. 2000, 43, 4377−4387.
(32) Sambrook, J.; Fritsch, E. F.; Maniatis, T. Molecular Cloning: A
Laboratory Manual, 2nd ed.; Cold Spring Harbor Laboratory Press:
Cold Spring Harbor, NY, 1989.
(33) Hansen, M.-B.; Neilson, S. E.; Berg, K. Re-examination and
further development of a precise and rapid dye method for measuring
cell growth/cell kill. J. Immunol. Methods 1989, 119, 203−210.
(34) Bajaj, A.; Kondiah, P.; Bhattacharya, S. Design, synthesis and in
vitro gene transfection efficacies of cholesterol based gemini lipids and
their serum compatibility: a structure activity relationship. J. Med.
Chem. 2007, 50, 2432−2442.
(35) Bajaj, A.; Kondaiah, P.; Bhattacharya, S. Synthesis and gene
transfer activities of novel serum compatible cholesterol based gemini
lipids possessing oxy-ethylene type spacers. Bioconjugate Chem. 2007,
18, 1537−1546.
(36) Matsui, K.; Sando, S.; Sera, T.; Aoyama, Y.; Sasaki, Y.; Komatsu,
T.; Terashima, T.; Kikuchi, J.-I. Cerasome as an infusible, cell-friendly,
and serum-compartible transfection agent in a viral size. J. Am. Chem.
Soc. 2006, 128, 3114−3115.
(37) Karmali, P. P.; Majeti, B. K.; Sreedhar, B.; Chaudhuri, A. In vitro
gene transfer efficacies and serum compatibility profiles of novel
mono-, di-, and tri-histidinylated cationic transfection lipids: a
structure-activity investigation. Bioconjugate Chem. 2006, 17, 159−171.
(38) Scriou, V.; Ciolina, C.; Lacroix, F.; Byk, G.; Scherman, D.; Wils,
P. Cationic lipid-mediated gene transfer: effect of serum on cellular
uptake and intracellular fate of lipopolyamine/DNA complexes.
Biochim. Biophys. Acta 1998, 1368, 276−288.
(39) Vitiello, L.; Bockhold, K.; Joshi, P. B.; Worton, R. G.
Transfection of cultured myoblasts in high serum concentration with
DODAC: DOPE liposomes. Gene Ther. 1998, 5, 1306−1313.
(40) Turek, J.; Dubertret, C.; Jaslin, G.; Antonakis, K.; Scherman, D.;
Pitard, B. Formulations which increase the size of lipoplexes prevent
serum-associated inhibition of transfection. J. Gene Med. 2000, 2, 32−
40.
(11) Koynova, R.; Tenchov, B. Recent patents in cationic lipid
carriers for delivery of nucleic acids. Recent Pat. DNA Gene Seq. 2011, 5
(1), 8−27.
(12) Koynova, R.; Tenchov, B. Cationic lipids: molecular structure/
transfection activity relationships and interactions with biomembranes.
Top. Curr. Chem. 2010, 296, 51−93.
(13) de Jesus, M. B.; Ferreira, C. V.; de Paula, E.; Hoekstra, D.;
Zuhorn, I. S. Design of solid lipid nanoparticles for gene delivery into
prostate cancer. J. Controlled Release 2010, 148 (1), 89−90.
(14) Hoekstra, D.; Rejman, J.; Wasungu, L.; Shi, F.; Zuhorn, I. Gene
delivery by cationic lipids: in and out of an endosome. Biochem. Soc.
Trans. 2007, 35 (Part 1), 68−71.
(15) Zuhorn, I. S.; Engberts, J. B.; Hoekstra, D. Gene delivery by
cationic lipid vectors: overcoming cellular barriers. Eur. Biophys. J.
2007, 36 (4−5), 349−362.
(16) Wasungu, L.; Hoekstra, D. Cationic lipids, lipoplexes and
intracellular delivery of genes. J. Controlled Release 2006, 116 (2),
255−264.
(17) Caracciolo, G.; Pozzi, D.; Caminiti, R.; Marchini, C.; Montani,
M.; Amici, A.; Amenitsch, H. Transfection efficiency boost by designer
multicomponent lipoplexes. Biochim. Biophys. Acta 2007, 1768 (9),
2280−2292.
(18) Li, W.; Szoka, F. C. Jr. Lipid-based nanoparticles for nucleic
acid delivery. Pharm. Res. 2007, 24 (3), 438−449.
(19) Singh, R. S.; Mukherjee, K.; Banerjee, R.; Chaudhuri, A.; Hait, S.
K.; Moulik, S.; Ramadas, Y.; Vijayalakshmi, A.; Rao, N. M. Anchor
dependency for non-glycerol based cationic lipofectins: mixedbag of
regular and anomalous transfection profiles. Chem.Eur. J. 2002, 8,
900−909.
(20) Koynova, R.; Tenchov, B.; Wang, L.; Macdonald, R. C.
Hydrophobic moiety of cationic lipids strongly modulates their
transfection activity. Mol. Pharm. 2009, 6 (3), 951−958.
(21) Felgner, J. H.; Kumar, R.; Sridhar, C. N.; Wheeler, C. J.; Tsai, Y.
J.; Border, R.; Ramsey, P.; Martin, M.; Felgner, P. L. Enhanced gene
delivery and mechanism studies with a series of cationic lipid
formulations. J. Biol. Chem. 1994, 269, 2550−2561.
(22) Majeti, B. K.; Singh, R. S.; Yadav, S. K.; Reddy, S. B.;
Ramkrishna, S.; Diwan, P. V.; Madhavendra, S. S.; Chaudhuri, A.
Enhanced intravenous transgene expression in mouse lung using
cyclic-head cationic lipids. Chem. Biol. 2004, 11, 427−437.
(23) Bhavani, K.; Srilakshmi, P. V. Influence of Minor Backbone
Structural Variations in Modulating the in Vitro Gene Transfer
Efficacies of α-Tocopherol Based Cationic Transfection Lipids.
Bioconjugate Chem. 2011, 22 (12), 2581−2592.
(41) Thierry, A. R.; Rabinovich, P.; Peng, B.; Mahan, L. C.; Bryant, J.
L.; Gallo, R. C. Characterization of liposome-mediated gene delivery:
expression, stability and pharmacokinetics of plasmid DNA. Gene Ther.
1997, 4, 226−237.
(24) Rajesh, M.; Sen, J.; Srujan, M.; Mukherjee, K.; Sridhar, B.;
Chaudhuri, A. Dramatic influence of the orientation of linker between
hydrophilic and hydrophobic lipid moiety in liposomal gene delivery. J.
Am. Chem. Soc. 2007, 129, 11408−11420.
(25) Mukthavaram, R.; Marepally, S.; Mahidhar, Y. V.; Naidu, V. G.
M.; Ramakrishna, S.; Chaudhuri, A. Cationic glycolipids with cyclic
and open galactose head-groups for the selective targeting of genes to
mouse liver. Biomaterials 2009, 30, 2369−2384.
(26) Bhavani, K.; Srilakshmi, P. V. Design, synthesis and in vitro
transfection biology of novel tocopherol based monocationic lipids: a
structure activity investigation. J. Med. Chem. 2011, 54 (2), 548−561.
(27) Wasungu, L.; Stuart, M. C.; Scarzello, M.; Engberts, J. B.;
Hoekstra, D. Lipoplexes formed from sugar-based gemini surfactants
undergo a lamellar-to-micellar phase transition at acidic pH. Evidence
for a non-inverted membrane-destabilizing hexagonal phase of
lipoplexes. Biochim. Biophys. Acta 2006, 1758 (10), 1677−1684.
(28) Dauty, E.; Remy, J.-S.; Blessing, T.; Behr, J.-P. Dimerizable
cationic detergents with a low cmc condense plasmid DNA into
nanometreic particles and transfect cells in cluture. J. Am. Chem. Soc.
2001, 123, 9227−9234.
(42) Zelphati, O.; Uyechi, L. S.; Barron, L. G.; Szoka, F. C. Jr. Effect
of serum components on the physico-chemical properties of cationic
lipid/oligonucleotide complexes and on their interactions with cells.
Biochim. Biophys. Acta 1998, 1390, 119−133.
(43) Yang, J. P.; Huang, L. Time-dependent maturation of cationic
liposome−DNA complex for serum resistance. Gene Ther. 1998, 5,
380−387.
(44) Yang, J. P.; Huang, L. Overcoming the inhibitory effect of serum
on lipofection by increasing the charge ratio of cationic liposome to
DNA. Gene Ther. 1997, 4, 950−960.
(45) Li, S.; Tseng, W. C.; Stolz, D. B.; Wu, S. P.; Watkins, S. C.;
Huang, L. Dynamic changes in the characteristics of cationic lipidic
vectors after exposure to mouse serum: implications for intravenous
lipofection. Gene Ther. 1999, 6, 585−594.
(46) Jones, D. P.; Kurtz, J. C.; Samiec, P. S.; Sternberg, P.; Reed, R.
L.; Brown, L. A. S. GSH measurement in human plasma. Evaluation of
sample collection storage and derivatization conditions for analysis of
dansyl derivatives by HPLC. Clin. Chem. Acta 1998, 275, 175−184.
(47) Anderson, M. E. Glutathione: anoverview of biosynthesis and
modulation. Chem. Biol. Interact. 1998, 111−112, 1−14.
1161
dx.doi.org/10.1021/mp200435y | Mol. Pharmaceutics 2012, 9, 1146−1162